The Hormone Replacement Therapy Market is estimated to grow at a CAGR of 6.48% during the forecast period from 2024 to 2030.

Merck & Co. Inc. managers escaped allegations that they hurt the pharmaceutical giant by misleading investors over traction ...

Henkel delivered solid results in 2024 and is in excellent financial shape. Click here to read an analysis of HENKY stock now ...

Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome ...

Borussia Dortmund have agreed a new deal with Under-19 head coach Mike Tullberg, the club have announced. In the process of ...

A tricky buy-out clause coupled with the start date of the FIFA Club World Cup is complicating BVB’s intentions with Carney ...

Borussia Dortmund have agreed a new deal with Under-19 head coach Mike Tullberg, the club have announced. In the process of ...

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market.

This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter. Merck is constructing a $1 billion drug ...

ESG/SustainabilityAsklepios Group: Publication of Asklepios CSRD Report 2024 30.04.2025 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Asklepios Group: ...

Merck is going all-in on domestic drug manufacturing with a $1 billion Delaware facility aimed at dodging Trump-era tariff ...